⏳ Fetching live dividend data...
Home › Calculator › OXBOF Dividend Calculator 2026
Oxford BioDynamics Plc · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in OXBOF → $3.279419577083349e+42M in 10 years · $273,284,751,253,233,900,000,000,000,000,000,000,000,000,000,000.00/month
Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the United States. Central to its operations is EpiSwitch, a proprietary technology platform. This platform facilitates the identification, evaluation, validation, and continuous monitoring of epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These biomarkers are utilized in various applications, including medical testing kits, predicting disease onset or progression, aiding in diagnosis, and informing treatment approaches. Among its innovative products are the EpiSwitch CiRT, a validated prognostic tool for anticipating patient response to checkpoint inhibitor immunotherapy; the EpiSwitch CST, an advanced blood assay designed to forecast the severity of COVID-19 in adult patients; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome profiling and the identification of new biomarkers.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OXBOF position with:
Real after-tax yield depends on where you live and how you hold OXBOF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 125000.00% | 124997.20% | $12,500,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 106250.00% | 106247.20% | $10,625,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 100000.00% | 99997.20% | $10,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 125000.00% | 124997.20% | $12,500,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 114062.50% | 114059.70% | $11,406,250 / yr |
| 🇨🇦 TFSA | 0% | 125000.00% | 124997.20% | $12,500,000 / yr |
| 🇨🇦 CA Taxable | 25% | 93750.00% | 93747.20% | $9,375,000 / yr |
| 🇦🇺 Super (pension) | 15% | 106250.00% | 106247.20% | $10,625,000 / yr |
| 🇦🇺 AU Taxable | 30% | 87500.00% | 87497.20% | $8,750,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 92031.25% | 92028.45% | $9,203,125 / yr |
| 🇫🇷 FR Taxable | 30% | 87500.00% | 87497.20% | $8,750,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
OXBOF pays quarterly — 4 times per year. Next ex-div: TBD.
How OXBOF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OXBOF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OXBOF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Oxford BioDynamics Plc (OXBOF) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 125000.00% based on an annual payout of $2.00 per share.
Oxford BioDynamics Plc (OXBOF) is a healthcare stock currently trading at $0.00 with a dividend yield of 125000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever